| 4O0B: reference: Identification of novel HSP90alpha/beta isoform selective inhibitors using structure-based drug design. Demonstration of potential utility in treating CNS disorders such as Huntington's disease., Ernst J, Neubert T, Liu M, Sperry S, Zuccola H, Turnbull A, Fleck B, Kargo W, Woody L, Chiang P, Tran D, Chen W, Snyder PW, Alcacio T, Nezami A, Reynolds J, Alvi K, Goulet L, Stamos D, J Med Chem. 2014 Mar 27. PMID: 24673104 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).